PRIMARY DOCUMENT

Company

Monopar Therapeutics

Filed

December 23, 2019

Accession Number

0001654954-19-014158

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →